Project Grant R01DK140039

Award Date 7/22/24
Completion Date 6/30/29
Dollars Obligated $633K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Richardson, TX 75080, USA
Similar Awards
This $521,019 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to evaluate and identify the communication between urothelial cells, sensory neurons, and the brain. The grant supports research at the Medical College of Wisconsin, Inc. to functionally and molecularly characterize the sensory neurons that respond to direct stimulation of...
This five-year Project Grant award, valued at $153,540, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research by Dr. Katherine Xu at Columbia University's Health Sciences Division to identify genetic risk factors and underlying mechanisms associated with urinary tract infections (UTIs). The research aims to perform genome-wide...
The federal Project Grant award of $117,000 was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award was granted to the Research Institute at Nationwide Children's Hospital (RINCH), a prominent non-profit research organization, to define the role of the STAT3 signaling pathway and its downstream targets in conferring host immunity against urinary tract...
This Project Grant award for $690,451 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funding supports research at the University of Pittsburgh to investigate the role of bladder fibroblasts, specifically suburothelial fibroblasts (SUFs), in regulating bladder function and sensation. The research aims to determine the molecular mechanisms by which SUFs...
This Project Grant award of $249,951 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop a novel tool called BACTVUE for the targeted ablation of infected bladder tissue in patients with antibiotic-refractory urinary tract infections (UTIs). The primary objectives are to demonstrate BACTVUE's ability to selectively stain diverse intracellular...
The University of California, San Diego (UCSD) has been awarded a $664,744 project grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The purpose of this 3-year award is to conduct a randomized Phase I/II pilot clinical trial to evaluate the safety, tolerability, feasibility, and efficacy of phage therapy in reducing recurrent urinary tract infections (UTIs) in...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund research to investigate the role of intercalated cells in the kidney's innate defense against urinary tract infections. The research team at Indiana University Indianapolis will examine the STAT3 signaling pathway and its regulation of intercalated cell phagocytosis and phagosome pH...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $299,608 to investigate the role of Proteus mirabilis RTX proteins in polymicrobial biofilm formation and the pathogenesis of catheter-associated urinary tract infections (CAUTI). The key objectives are to: 1) Examine the expression of P. mirabilis RTX proteins during polymicrobial biofilm formation and determine their...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will provide $625,060.00 to The Washington University in St. Louis to conduct research on the roles of distinct spinal cord cell types in mediating interstitial cystitis (IC)/bladder pain syndrome (BPS). The research aims to elucidate how different spinal cord cells activated by cystitis...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $730,883 to the Icahn School of Medicine at Mount Sinai to conduct research on the molecular and cellular mechanisms underlying visceral pain and cross-organ sensitization. The key objectives are to: Investigate the role of MRGPRB2+ mast cell-TRPV1+ nociceptor clusters in bladder pain and...

This $632,600 federal Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to analyze the role of antimicrobial peptides called defensins in immune response and pain associated with urinary tract infections (UTIs). The project aims to utilize genetic tools to understand how defensins synthesized by bladder epithelial cells contribute to immunity against uropathogenic E. coli, characterize the defensin-related immune response using single-cell RNA sequencing, and test the hypothesis that defensins released during UTIs activate pain-sensing neurons. A sub-award to Vanderbilt University Medical Center will support primary bladder epithelial cell culture and infection assays. The overarching goal is to develop better treatments for UTIs by targeting specific immune defensin receptors to enhance innate immunity while limiting painful side effects.

Generated 6/24/25, 6:22 AM